Si-Bone (SIBN) Cash & Equivalents (2017 - 2026)

Si-Bone has reported Cash & Equivalents for 10 years, with the latest figure at $33.1 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 2.99% year-over-year to $33.1 million in Q2 2026; TTM through Jun 2026 was $33.1 million, a 2.99% decrease from a year earlier, with the FY2025 full-year figure at $42.2 million, up 20.87% from the prior year.
• Cash & Equivalents was $33.1 million for Q2 2026 at Si-Bone, down from $33.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $110.8 million in Q2 2023, with the low at $20.7 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $36.3 million, with a median of $32.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 355.67% in 2023, then plunged 76.92% in 2024.
• Over 5 years, Cash & Equivalents stood at $20.7 million in 2022, then surged by 60.6% to $33.3 million in 2023, then grew by 5.04% to $34.9 million in 2024, then gained by 20.87% to $42.2 million in 2025, then declined by 21.57% to $33.1 million in 2026.
• The last three Cash & Equivalents figures came in at $33.1 million (Q2 2026), $33.5 million (Q1 2026), and $42.2 million (Q4 2025), per Business Quant data.